Bulletin
Investor Alert

AgeX Therapeutics Inc.

ASE: AGE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 23, 2021, 7:34 p.m.

AGE
/zigman2/quotes/208090696/composite

$

1.60

Change

+0.10 +6.67%

Volume

Volume 7,369

Quotes are delayed by 20 min

/zigman2/quotes/208090696/composite

Previous close

$ 1.53

$ 1.50

Change

-0.03 -1.96%

Day low

Day high

$1.40

$1.54

Open

52 week low

52 week high

$0.75

$3.93

Open

Annual Financials for AgeX Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 1.67M1.4M1.4M1.73M1.87M
Cost of Goods Sold (COGS) incl. D&A 911,000685,000841,000998,5001.84M
COGS excluding D&A 66,0003,000306,00047,500158,000
Depreciation & Amortization Expense 845,000682,000535,000951,0001.68M
Depreciation 238,000165,00058,000393,0001.12M
Amortization of Intangibles 607,000517,000477,000558,000559,000
Gross Income 755,000719,000555,000729,50028,000
20162017201820192020 5-year trend
SG&A Expense 13.49M9.14M11M13.29M10.7M
Research & Development 7.87M5.27M5.35M5.35M4.42M
Other SG&A 5.62M3.87M5.65M7.94M6.28M
Other Operating Expense -----
Unusual Expense --800,000--
EBIT after Unusual Expense --(11.25M)--
Non Operating Income/Expense (4.59M)1.79M3.4M294,00044,000
Non-Operating Interest Income --116,00029,000-
Equity in Affiliates (Pretax) -----
Interest Expense 25,00012,000--499,000
Gross Interest Expense 25,00012,000--499,000
Interest Capitalized -----
Pretax Income (17.36M)(6.64M)(7.73M)(12.24M)(11.13M)
Income Tax ---148,000(150,000)
Income Tax - Current Domestic -----
Income Tax - Current Foreign ---148,000(150,000)
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (17.36M)(6.64M)(7.73M)(12.38M)(10.98M)
Minority Interest Expense (1.86M)(57,000)(229,000)(230,000)(111,000)
Net Income (15.49M)(6.58M)(7.5M)(12.15M)(10.87M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (15.49M)(6.58M)(7.5M)(12.15M)(10.87M)
Preferred Dividends -----
Net Income Available to Common (15.49M)(6.58M)(7.5M)(12.15M)(10.87M)
EPS (Basic) (0.43)(0.18)(0.21)(0.33)(0.29)
Basic Shares Outstanding 35.83M35.83M34.91M37.27M37.67M
EPS (Diluted) (0.43)(0.18)(0.21)(0.33)(0.29)
Diluted Shares Outstanding 35.83M35.83M34.91M37.27M37.67M
EBITDA (11.89M)(7.74M)(9.91M)(11.61M)(8.99M)
Link to MarketWatch's Slice.